AZELIRAGON
UNII LPU25F15UQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Azeliragon, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LPU25F15UQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 603148-36-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LPU25F15UQ

CAS Registry Number

603148-36-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AZELIRAGON

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C32H38ClN3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KJNNWYBAOPXVJY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C174675

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11180124

Unique identification number in the NCBI database of chemical substances.

INN ID

9945

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-169

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(Oc2ccc(cc2)Cl)ccc1-n3c(CCCC)nc(-c4ccc(OCCCN(CC)CC)cc4)c3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Azeliragon. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.